My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Public ClinicalTrials.gov record NCT02091141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
My Pathway: An Open-Label Phase IIa Study Evaluating Trastuzumab/Pertuzumab, Erlotinib, Vemurafenib/Cobimetinib, Vismodegib, Alectinib, and Atezolizumab in Patients Who Have Advanced Solid Tumors With Mutations or Gene Expression Abnormalities Predictive of Response to One of These Agents
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multicenter, non-randomized, open-label study will evaluate the efficacy and safety of six treatment regimens in participants with advanced solid tumors for whom therapies that will convey clinical benefit are not available and/or are not suitable options per the treating physician's judgment.
Study identification
- NCT ID
- NCT02091141
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 673 participants
Conditions and interventions
Interventions
- Trastuzumab Drug
- Pertuzumab Drug
- Erlotinib Drug
- Vemurafenib Drug
- Cobimetinib Drug
- Vismodegib Drug
- Alectinib Drug
- Atezolizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 14, 2014 (Actual)
- Primary completion
- May 24, 2023 (Actual)
- Completion
- May 24, 2023 (Actual)
- Last update posted
- Jul 23, 2024
2014 – 2023
United States locations
- U.S. sites
- 60
- U.S. states
- 25
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Western Regional Medical Center at Cancer Treatment Centers of America | Goodyear | Arizona | 85338 | — |
| Mayo Clinic Arizona | Phoenix | Arizona | 85259 | — |
| Highlands Oncology Group | Springdale | Arkansas | 72762 | — |
| Science 37, Inc | Culver City | California | 90230 | — |
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | — |
| Moores UCSD Cancer Center; Dept Clinical Trials Office | La Jolla | California | 92093-0698 | — |
| Eisenhower Medical Center | Rancho Mirage | California | 92270 | — |
| Stanford Comprehensive Cancer Center | Stanford | California | 94305 | — |
| Kaiser Permanente - Vallejo | Vallejo | California | 94589 | — |
| University of Colorado | Aurora | Colorado | 80045-2517 | — |
| SCRI Florida Cancer Specialists South | Fort Myers | Florida | 33916 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| Florida Hospital Cancer Inst; Memorial System Onc Clin Rsch | Orlando | Florida | 32804 | — |
| Florida Cancer Specialist, North Region | St. Petersburg | Florida | 33705 | — |
| Florida Cancer Specialists, Research Department | West Palm Beach | Florida | 33401 | — |
| University Cancer & Blood Center, LLC; Research | Athens | Georgia | 30607 | — |
| Northeast Georgia Medical Center; Oncology Research Dept-5C | Gainesville | Georgia | 30501 | — |
| Southeastern Regional Medical Center, Inc. | Newnan | Georgia | 30265 | — |
| Northwestern University; Robert H. Lurie Comp Can Ctr; Northwestern Medicine Development Inst | Chicago | Illinois | 60611 | — |
| University Of Chicago Medical Center; Section Of Hematology/Oncology | Chicago | Illinois | 60637 | — |
| Midwestern Regional Med Center | Zion | Illinois | 60099 | — |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | Maryland | 21287 | — |
| Mayo Foundation | Rochester | Minnesota | 55905 | — |
| Research Medical Center - Antibiotic Research Associates, Inc. | Kansas City | Missouri | 64132 | — |
| Memorial Sloan Kettering - Monmouth | Middletown | New Jersey | 07748 | — |
| University of New Mexico Comprehensive Cancer Center | Albuquerque | New Mexico | 87102 | — |
| University of New Mexico Comprehensive Cancer Center - Albuquerque Cedar Street; Drug Shipment | Albuquerque | New Mexico | 87106 | — |
| University of New Mexico Comprehensive Cancer Center - Albuquerque Lang NE; Drug Shipment | Albuquerque | New Mexico | 87109 | — |
| University of New Mexico | Albuquerque | New Mexico | 87131 | — |
| San Juan Oncology Associates | Farmington | New Mexico | 87401 | — |
| Memorial Sloan Kettering Cancer Center at Westchester | Harrison | New York | 10604 | — |
| Weill Cornell Univ Medical Ctr; Breast Cancer Center | New York | New York | 10021 | — |
| Herbert Irving Comprehensive Cancer Center; Herbert Irving Pavillion | New York | New York | 10032 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Univ No Carolina School of Med; Physicians Office Bldg | Chapel Hill | North Carolina | 27599-7305v | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Wake Forest Univ Health Svcs; Internal Medicine | Winston-Salem | North Carolina | 27157 | — |
| Sanford Roger Maris Cancer Center | Fargo | North Dakota | 58102 | — |
| Oncology Hematology Care Inc | Cincinnati | Ohio | 45242 | — |
| Cleveland Clinic | Cleveland | Ohio | 44106 | — |
| University Hospitals of Cleveland | Cleveland | Ohio | 44106 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Abramson Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Eastern Regional Medical Ctr | Philadelphia | Pennsylvania | 19124 | — |
| UPMC - Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| Abington Mem Hosp-Abington; Rose. Can Ctr,Gyn Onc Ins | Willow Grove | Pennsylvania | 19090 | — |
| Sanford Cancer Cnt Onco Clinic | Sioux Falls | South Dakota | 57104 | — |
| Sarah Cannon Research Institute / Tennessee Oncology | Chattanooga | Tennessee | 37404 | — |
| West Clinic | Germantown | Tennessee | 38138 | — |
| Tennessee Cancer Specialists | Knoxville | Tennessee | 37920 | — |
| Tennessee Oncology - Nashville | Nashville | Tennessee | 37203 | — |
| Vanderbilt Ingram Cancer Clinic | Nashville | Tennessee | 37232 | — |
| The Center for Cancer and Blood Disorders - Fort Worth | Fort Worth | Texas | 76104 | — |
| MD Anderson | Houston | Texas | 77030 | — |
| Virginia Cancer Institute | Richmond | Virginia | 23229 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
| University of Wisconsin | Madison | Wisconsin | 53705 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02091141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2024 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02091141 live on ClinicalTrials.gov.